Groep Brussel Lambert NV (GBLBF)

Groep Brussel Lambert NV is a Belgium-based investment holding company listed on OTC Markets under the common stock classification. Through its portfolio, the company has exposure to industrial, consumer goods, and business services businesses across Belgium, other European countries, North America, and other international markets. Its activities are organized around six segments: Holding, Imerys, Canyon, Affidea, Sanoptis, and GBL Capital and Sienna Investment Managers. Founded in 1902 and headquartered in Brussels, the company has long operated as a diversified holding vehicle with interests in multiple sectors and geographies.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Payout Ratio Free Cash Flow / Net Income
OTC-GBLB.F
$62.36
-29.5% Downside
Overvalued
Not available
Not available
Fair
6.8%
February 25, 2027
0.9x
1.4x
10.49 B
17.26 B
45.5%
52.5%
-99.9%
57.3%
Valuation • Fair Value

Groep Brussel Lambert NV (OTC-GBLB.F) Fair Value by Valuation Model

Review the available estimates for Groep Brussel Lambert NV (OTC-GBLB.F), including DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$62.36

Estimated downside of 29.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DDM Fair Value

$43.96

Dividend discount model valuation reference.

Comps Fair Value

$71.56

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Groep Brussel Lambert NV (OTC-GBLB.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Groep Brussel Lambert NV (OTC-GBLB.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

7.781 B

Current operating scale indicator.

Revenue Forecast

7.255 B

Forward revenue estimate.

EBITDA

1.216 B

Current operating profitability reference.

EBITDA Forecast

870 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Groep Brussel Lambert NV (OTC-GBLB.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Groep Brussel Lambert NV (OTC-GBLB.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

4

Mid-range quality score.

FCF / Net Income

57.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Groep Brussel Lambert NV (OTC-GBLB.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Groep Brussel Lambert NV (OTC-GBLB.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

February 25, 2027

Days to Earnings

104

Dividend Yield

6.8%

Current income yield reference.

Payout Ratio

-99.9%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Groep Brussel Lambert NV (OTC-GBLB.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Groep Brussel Lambert NV (OTC-GBLB.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Groep Brussel Lambert NV (OTC-GBLB.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Groep Brussel Lambert NV (OTC-GBLB.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Groep Brussel Lambert NV (OTC-GBLB.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Groep Brussel Lambert NV (OTC-GBLB.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Groep Brussel Lambert NV (OTC-GBLB.F) Stock FAQ

Data-supported answers about Groep Brussel Lambert NV (OTC-GBLB.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$62.36
Estimated downside 29.5%
Valuation Rating
Overvalued
Estimated downside of 29.5%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Groep Brussel Lambert NV (OTC-GBLB.F) is $62.36. This implies an estimated downside of 29.5% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 29.5% versus the current market price.

The current financial health read for Groep Brussel Lambert NV (OTC-GBLB.F) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Groep Brussel Lambert NV (OTC-GBLB.F) is February 25, 2027.

Based on the current data, dividend yield is 6.8%.

The current market capitalization listed for Groep Brussel Lambert NV is 10.49 B.

The current enterprise value listed for Groep Brussel Lambert NV is 17.26 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Groep Brussel Lambert NV is OTC-GBLB.F, and the stock is listed on OTC Markets.

Groep Brussel Lambert NV (OTC-GBLB.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Groep Brussel Lambert NV is 45.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Groep Brussel Lambert NV is 52.5%. Free float helps investors understand how much of the share base is available for public trading.